• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Hajime Uno, PhD


  • Brooks GA, Abrams TA, Meyerhardt JA, Enzinger PC, Sommer K, Dalby CK, Uno H, Jacobson JO, Fuchs CS, Schrag D.Identification of potentially avoidable hospitalizations in patients with GI cancer.J Clin Oncol. 2014 Feb 20(6):496-503.
  • Skali H, Lin J, Pfeffer MA, Chen CY, Cooper ME, McMurray JJ, Nissenson AR, Remuzzi G, Rossert J, Parfrey PS, Scott-Douglas NW, Singh AK, Toto R, Uno H, Ivanovich P.Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.Am J Kidney Dis. 2013 Feb;61(2):238-46.
  • Barkoudah E, Skali H, Uno H, Solomon SD, Pfeffer MA.Mortality rates in trials of subjects with type 2 diabetes.J Am Heart Assoc. 2012 Feb;1(1):8-15.
  • Zhao L, Tian L, Uno H, Solomon SD, Pfeffer MA, Schindler JS, Wei LJ.Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.Clin Trials. 2012;9(5):570-7.
  • Cai T, Tian L, Uno H, Solomon SD, Wei LJ.Calibrating parametric subject-specific risk estimation.Biometrika. 2010 Jun;97(2):389-404.
  • Uno H, Tian L, Cai T, Kohane IS, Wei LJ.A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data.Stat Med. 2012 Oct 5.
  • Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D.Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):234-43.
  • Cesano A, Rosen DB, O'Meara P, Putta S, Gayko U, Spellmeyer DC, Cripe LD, Sun Z, Uno H, Litzow MR, Tallman MS, Paietta E.Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: effect of specimen source (bone marrow or peripheral blood) on assay readouts.Cytometry. Part B, Clinical Cytometry. 2012 May;82(3):158-72.
  • Skali H, Parving HH, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P, Keithi-Reddy SR, McGill JB, McMurray JJ, Singh AK, Solomon SD, Uno H, Pfeffer MA, .Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.Circulation. 2011 Dec 20;124(25):2903-8.
  • Pouleur AC, Uno H, Prescott MF, Desai A, Appelbaum E, Lukashevich V, Smith BA, Dahlöf B, Solomon SD, .Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):483-90.
  • Kumar SK, Uno H, Jacobus SJ, Van Wier SA, Ahmann GJ, Henderson KJ, Callander NS, Haug JL, Siegel DS, Greipp PR, Fonseca R, Rajkumar SV.Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone.Blood. 2011 Oct 20;118(16):4359-62.
  • Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, Levey AS, Lewis EF, McMurray JJ, Parving HH, Solomon SD, Pfeffer MA.Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.Am J Kidney Dis. 2011 Nov;58(5):717-28.
  • Jacobus SJ, Kumar S, Uno H, Van Wier SA, Ahmann GJ, Henderson KJ, Callander NS, Williams ME, Siegel DS, Greipp PR, Rajkumar SV, Fonseca R.Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03.British Journal of Haematology. 2011 Nov;155(3):340-8.
  • McMurray JJ, Uno H, Jarolim P, Desai AS, de Zeeuw D, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, Parfrey P, Parving HH, Toto RM, Solomon SD, Pfeffer MA.Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT).Am Heart J. 2011 Oct;162(4):748-755.e3.
  • Skali H, Uno H, Levey AS, Inker LA, Pfeffer MA, Solomon SD.Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.Am Heart J. 2011 Sep;162(3):548-54.
  • Lyons JL, Uno H, Ancuta P, Kamat A, Moore DJ, Singer EJ, Morgello S, Gabuzda D.Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):371-9.
  • Knappe D, Pouleur AC, Shah AM, Cheng S, Uno H, Hall WJ, Bourgoun M, Foster E, Zareba W, Goldenberg I, McNitt S, Pfeffer MA, Moss AJ, Solomon SD, .Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.Circ Heart Fail. 2011 Jul;4(4):433-40.
  • Pouleur AC, Knappe D, Shah AM, Uno H, Bourgoun M, Foster E, McNitt S, Hall WJ, Zareba W, Goldenberg I, Moss AJ, Pfeffer MA, Solomon SD, .Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.Eur Heart J. 2011 Jul;32(14):1720-9.
  • Ye S, Grunnert M, Thune JJ, Stephenson KM, Uno H, Finn PV, McMurray JJ, Velazquez EJ, Califf R, Pfeffer MA, Solomon SD.Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention.Circulation. 2011 Jun 14;123(23):2674-80.
  • Vardeny O, Uno H, Braunwald E, Rouleau JL, Gersh B, Maggioni AP, Domanski M, Pfeffer MA, Solomon SD, .Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease.Am J Cardiol. 2011 Jun 15;107(12):1705-9.
  • Uno H, Cai T, Tian L, Wei LJ.Graphical Procedures for Evaluating Overall and Subject-Specific Incremental Values from New Predictors with Censored Event Time Data.Biometrics. 2011 Apr 19.
  • Uno H, Cai T, Pencina MJ, D'Agostino RB, Wei LJ.On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.Stat Med. 2011 May 10;30(10):1105-17.
  • Cripe LD, Uno H, Paietta EM, Litzow MR, Ketterling RP, Bennett JM, Rowe JM, Lazarus HM, Luger S, Tallman MS.Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.Blood. 2010 Nov 18;116(20):4077-85.
  • Solomon SD, Uno H, Lewis EF, Eckardt KU, Lin J, Burdmann EA, de Zeeuw D, Ivanovich P, Levey AS, Parfrey P, Remuzzi G, Singh AK, Toto R, Huang F, Rossert J, McMurray JJ, Pfeffer MA, .Erythropoietic response and outcomes in kidney disease and type 2 diabetes.N Engl J Med. 2010 Sep 16;363(12):1146-55.
  • Gertz MA, Abonour R, Heffner LT, Greipp PR, Uno H, Rajkumar SV.Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.British Journal of Haematology. 2009 Dec;147(5):677-80.
  • Yonemori K, Katsumata N, Noda A, Uno H, Yunokawa M, Nakano E, Kouno T, Shimizu C, Ando M, Tamura K, Takeuchi M, Fujiwara Y.Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.J Cancer Res Clin Oncol. 2008 Nov;134(11):1199-206.
  • Yonemori K, Tateishi U, Uno H, Yonemori Y, Tsuta K, Takeuchi M, Matsuno Y, Fujiwara Y, Asamura H, Kusumoto M.Development and validation of diagnostic prediction model for solitary pulmonary nodules.Respirology. 2007 Nov;12(6):856-62.
  • Yonemori K, Katsumata N, Kaneko M, Uno H, Matsumoto K, Kouno T, Shimizu C, Ando M, Takeuchi M, Fujiwara Y.Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy.Breast Cancer Res Treat. 2007 Jul;103(3):313-8.
  • Tateishi U, Uno H, Yonemori K, Satake M, Takeuchi M, Arai Y.Prediction of lung adenocarcinoma without vessel invasion: a CT scan volumetric analysis.Chest. 2005 Nov;128(5):3276-83.
  • Yonemori K, Katsumata N, Uno H, Matsumoto K, Kouno T, Tokunaga S, Yamanaka Y, Shimizu C, Ando M, Takeuchi M, Fujiwara Y.Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer.Breast Cancer Res Treat. 2005 Feb;89(3):237-41.